Kirkland Advises Carlyle on $3.8 Billion Acquisition of Baxter’s Kidney Care Segment

Advising firms

The announcement does not name individual lawyers.

Stated terms

Stated value

USD 3.80bn ($3.8 billion)

What the figure measures

Total transaction value

Client

CarlyleBuy-side

Counterparties

Baxter International Inc. (Sell-side)
Atmas Health (Joint venture party)